@article{fedcc6e5562f46e2a8b244d819e538e6,
title = "Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): Double blind randomised controlled trial",
author = "Kovacs, {Michael J.} and Wells, {Philip S.} and Anderson, {David R.} and Alejandro Lazo-Langner and Clive Kearon and Bates, {Shannon M.} and Mark Blostein and Kahn, {Susan R.} and Sam Schulman and Elham Sabri and Susan Solymoss and Tim Ramsay and Erik Yeo and Rodger, {Marc A.}",
note = "Funding Information: PERIOP2 was a randomised, double blind, placebo controlled trial. The protocol was designed by the steering committee and approved by the institutional review board at each participating centre. The study was funded by the Canadian Institute of Health Research (CIHR-MCT79607) and had support from Pfizer in the form of the study drug. The trial was registered at ClinicalTrials.gov (NCT00432796). Pfizer did not have any role in the design or conduct of the study, analysis of the data, or preparation of the manuscript. The study drugs (dalteparin or placebo) were prepared in each local centre by pharmacists not involved in the patient{\textquoteright}s care. Funding Information: The authors dedicate this work to the memory of Clive Kearon, Linda Vickars, and Susan Solymoss, accomplished researchers and dear friends. We acknowledge Guillaume Feugere and Christian Caldji from Pfizer. This study would not have been possible without the contribution of all of the investigators and research coordinators. Finally, we thank all of the patients involved for their vital contribution to this study. MJK, PSW, DRA, ALL, CK, SMB, MB, SRK, SSc, SSo, TR, EY, and MAR are investigators of the CanVECTOR Network; the Network receives grant funding from the Canadian Institutes of Health Research (CDT-142654). The results reported in this paper were presented in part at the American Society of Hematology (ASH) annual meeting in December 2018 in San Diego, CA, USA. Publisher Copyright: {\textcopyright} The Author(s), 2021.",
year = "2021",
month = jun,
day = "9",
doi = "10.1136/bmj.n1205",
language = "English",
volume = "373",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
}